Procalcitonin as a Predictive Marker of Incident Liver Disease
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Elevated procalcitonin (PCT) levels independently predict future non-viral liver disease risk. This finding suggests PCT may be a useful biomarker for assessing liver disease risk and potentially a direct cause of liver damage.
Area Of Science
- Biochemistry
- Hepatology
- Clinical Biomarkers
Background
- Procalcitonin (PCT) concentrations are known to be elevated in liver disease patients without bacterial infections.
- Previous research indicates a potential link between PCT and liver health.
Purpose Of The Study
- To investigate the association between elevated procalcitonin (PCT) levels and the future risk of developing non-viral liver disease.
- To determine if PCT can serve as an independent predictor for liver disease incidence.
Main Methods
- Procalcitonin (PCT) levels were measured in two large cohorts (MDC-CC and MPP) comprising nearly 8000 individuals without known liver disease.
- Cox proportional hazards regression models were employed to analyze the risk of incident liver disease based on PCT levels.
- Multivariate adjusted models and cohort-specific sensitivity analyses, including C-reactive protein, were performed.
Main Results
- In a pooled analysis of both cohorts, individuals with high PCT (>0.05 ng/mL) showed a significantly increased risk of developing non-viral liver disease (HR 3.4, p < 0.001).
- Each standard deviation increase in log-transformed PCT was associated with a 1.56-fold increased risk of liver disease (p < 0.001).
- Sensitivity analyses confirmed these findings, even after adjusting for C-reactive protein.
Conclusions
- Elevated procalcitonin (PCT) concentration is an independent predictor of non-viral liver disease.
- These findings have implications for liver disease risk assessment.
- The study suggests procalcitonin (PCT) might play a role as a direct cause of hepatocyte damage.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...